Mark Keatley

Mark Keatley, born in 1957, holds a MA and MPhil from Cambridge University and an MBA from Stanford Graduate School of Business. Mark Keatley has been CFO of STADA AG and Actavis Group, two leading European manufacturers of generic and OTC medicines. He is a Board member of Recipharm AB and Neuraxpharm AG. Previously he has served as a board member of MS Pharma and Medichem, S.A., as a Senior Partner at Albrecht Prock & Partners AB, as CFO of companies in contract manufacturing, biotechnology, and natural resources, and as a Division Manager at the International Finance Corporation.